Ocumetics Technology Corp.
TSXV:OTC.V
0.3 (CAD) • At close March 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.045 | 0.033 | 0.035 | 0.03 | 0.026 | 0.026 | 0.027 | 0.025 | 0.025 | 0.025 | 0.026 | 0 | 0 | 0 |
Gross Profit
| -0.045 | -0.033 | -0.035 | -0.03 | -0.026 | -0.026 | -0.027 | -0.025 | -0.025 | -0.025 | -0.026 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0.248 | 0.185 | 0.282 | 0.27 | 0.185 | 0.169 | 0.123 | 0.133 | 0.174 | 0.126 | 0.051 | 0 | 0 | 0 |
General & Administrative Expenses
| 0.328 | 0.356 | 0.368 | 0.399 | 1.189 | 0.408 | 0.346 | 0.317 | 0.456 | 0.34 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| -0.018 | 0.01 | 0.043 | 0.034 | 0.056 | 0.041 | 0.013 | 0.031 | -0.01 | 0.025 | 0 | 0 | 0 | 0 |
SG&A
| 0.311 | 0.399 | 0.397 | 0.433 | 1.245 | 0.449 | 0.359 | 0.347 | 0.445 | 0.365 | 0.412 | 0.01 | 0.042 | 0.013 |
Other Expenses
| 0.104 | 0 | 0 | 0 | 0 | 0 | -0.005 | -0.002 | -0.057 | -0.013 | 0 | 0 | 0 | 0 |
Operating Expenses
| 0.663 | 0.584 | 0.679 | 0.737 | 1.489 | 0.665 | 0.508 | 0.506 | 0.644 | 0.516 | 0.463 | 0.01 | 0.042 | 0.013 |
Operating Income
| -0.69 | -0.616 | -0.715 | -0.751 | -1.489 | -0.665 | -0.543 | -0.511 | -0.641 | -0.513 | -0.489 | -0.01 | -0.042 | -0.013 |
Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -0.019 | -0.015 | -0.005 | -0.006 | -0.003 | -0.003 | -0.008 | -0.005 | -0.004 | -0.002 | -0.005 | 0 | 0 | 0 |
Income Before Tax
| -0.768 | -0.631 | -0.72 | -0.749 | -1.499 | -0.676 | -0.543 | -0.511 | -0.648 | -0.518 | -0.494 | -0.01 | -0.042 | -0.013 |
Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0.105 | -0 | 0 | 0.007 | 0.007 | 0.007 | -0.061 | 0.005 | 0.004 | 0.002 | 0 | 0 | 0 | 0 |
Net Income
| -0.768 | -0.631 | -0.72 | -0.749 | -1.499 | -0.676 | -0.543 | -0.511 | -0.648 | -0.518 | -0.494 | -0.01 | -0.042 | -0.013 |
Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.007 | -0.005 | -0.006 | -0.006 | -0.013 | -0.006 | -0.005 | -0.005 | -0.006 | -0.005 | -0.005 | -0.003 | -0.014 | -0.004 |
EPS Diluted
| -0.007 | -0.005 | -0.006 | -0.006 | -0.013 | -0.006 | -0.005 | -0.005 | -0.006 | -0.005 | -0.005 | -0.003 | -0.014 | -0.004 |
EBITDA
| -0.612 | -0.584 | -0.679 | -0.706 | -1.462 | -0.639 | -0.569 | -0.475 | -0.616 | -0.488 | -0.463 | -0.01 | -0.042 | -0.013 |
EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |